Jazz Pharmaceuticals clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
12 trials changed in the last 30 days: 0 stopped, 5 with notable changes, 7 with minor changes only.
- Notable: CBD-OS · DEE Recruitment opened
- Minor: XYRISE · Xywav Expanded Dosing vs Placebo · Narcolepsy or IH Trial sites expanded: 15 → 27 locations
- Minor: EmpowHER 208 · Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy · HER2-positive Breast Cancer Trial sites expanded: 53 → 60 locations
- Notable: Lurbinectedin in Combination With Durvalumab · ES-SCLC Primary completion pushed from Jan 31, 2028 to Aug 4, 2029
- Notable: JZP269 in Healthy Male and Female Participants Recruitment opened
- Minor: Zanidatamab · HER2-expressing Tumors Trial sites expanded: 28 → 42 locations
- Minor: OPERA · Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting Trial completed
- Minor: JZP926 Capsule · Juvenile Myoclonic Epilepsy Trial sites expanded: 19 → 23 locations
- Minor: JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma Trial sites expanded: 5 → 8 locations
- Notable: ZOLA · Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA Start date pushed from Oct 1, 2026 to Nov 30, 2026
- Notable: Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms Primary completion pushed from Jul 2026 to Mar 31, 2027
- Minor: Food Effect of JZP047 in Healthy Participants Enrollment closed, study ongoing
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 6 | |
| Phase 1/2 | 1 | |
| Phase 2 | 5 | |
| Phase 2/3 | 1 | |
| Phase 3 | 6 | |
| Phase 4 | 2 |
Not charted: 3 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 20
Epilepsy (6) · Breast Cancer (3) · Esophageal Cancer (3) · Gastric Cancer (3) · HER2-Positive Cancer (3) · Lung Cancer (3) · Colorectal Cancer (2) · Glioma (2) · Head & Neck Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2)
Get alerts when Jazz Pharmaceuticals's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.